[{"AccountsPayableCurrent_0_Q1_USD":3148000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":30000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":19504000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":1444000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":17131000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":23263000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":445000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q1_USD":-123000.0,"AccruedBonusesCurrent_0_Q1_USD":2611000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-45000.0,"RealizedInvestmentGainsLosses_1_Q1_USD":-1000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-45000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":445000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q1_USD":20000.0,"OtherLiabilitiesCurrent_0_Q1_USD":3613000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":179000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":24609000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":0.0,"PrepaidInsurance_0_Q1_USD":288000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q1_USD":-24000.0,"OtherAssetsCurrent_0_Q1_USD":78000.0,"AccruedSalariesCurrent_0_Q1_USD":1631000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1_Q1_USD":997000.0,"PrepaidRent_0_Q1_USD":393000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q1_USD":9253000.0,"FinanceLeaseInterestExpense_1_Q1_USD":7000.0,"ImpairmentOfInvestments_1_Q1_USD":0.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-335000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":179000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":10300000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":123000.0,"OtherSundryLiabilitiesCurrent_0_Q1_USD":78000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q1_USD":-1000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-23000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.09,"OperatingLeaseRightOfUseAsset_0_Q1_USD":11055000.0,"OperatingLeasePayments_1_Q1_USD":1000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":10180000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3154000.0,"InvestmentIncomeInterest_1_Q1_USD":224000.0,"OperatingLeaseLiability_0_Q1_USD":13333000.0,"LitigationSettlementAmountAwardedToOtherParty_1_Q1_USD":12000000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":2671000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":3221000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3754000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3671000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":2545000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1083000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":1730000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":16004000.0,"InvestmentIncomeNet_1_Q1_USD":178000.0,"InterestReceivableCurrent_0_Q1_USD":205000.0,"InsuranceSettlementsReceivableCurrent_0_Q1_USD":29000.0,"MarketableSecuritiesGainLoss_1_Q1_USD":-1000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":2217000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-23000.0,"StockRepurchasedAndRetiredDuringPeriodShares_1_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":58539000.0,"ProfitLoss_1_Q1_USD":-18383000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3910000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":146000.0,"NetIncomeLoss_1_Q1_USD":-18383000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-12596000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":14163000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-123000.0,"LiabilitiesCurrent_0_Q1_USD":14248000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":127023000.0,"Liabilities_0_Q1_USD":24428000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-244000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-680574000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.19,"DueToRelatedPartiesCurrent_0_Q1_USD":853000.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":114000.0,"Depreciation_1_Q1_USD":2200000.0,"CommonStockValue_0_Q1_USD":10000.0,"CommonStockSharesOutstanding_0_Q1_shares":98498432.0,"CommonStockSharesIssued_0_Q1_shares":98498432.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":16952000.0,"AssetsCurrent_0_Q1_USD":44125000.0,"Assets_0_Q1_USD":127023000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5609478.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-128000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-18383000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q1_USD":18300000.0,"Revenues_1_Q1_USD":21000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":98472641.0,"StockIssued1_1_Q1_USD":0.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_1_Q1_USD":300000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-18406000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":783287000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":57000.0,"SecurityDeposit_0_Q1_USD":113000.0,"OtherAssetsNoncurrent_0_Q1_USD":4051000.0,"NonoperatingIncomeExpense_1_Q1_USD":203000.0,"DebtConversionConvertedInstrumentAmount1_1_Q1_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":182000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":32000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1097000.0,"StockholdersEquity_0_Q1_USD":102595000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":79363000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q1_USD":0.0,"ShareBasedCompensation_1_Q1_USD":445000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":5373000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":13234000.0,"OperatingIncomeLoss_1_Q1_USD":-18586000.0,"OperatingExpenses_1_Q1_USD":18607000.0,"InterestPaidNet_1_Q1_USD":7000.0,"IncomeTaxesPaidNet_1_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":6634000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":20824000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-23000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]